“Once again, we are extremely proud that the pivotal research stemming from the Lymphoma Research Foundation and its innovative research portfolio will be featured throughout this year’s ASH Annual Meeting,” said Dr. Leo I. Gordon, Chair of the LRF SAB.
New York, NY (PRWEB) December 01, 2016
The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services – will again be a feature of this year’s American Society of Hematology (ASH) Annual Meeting and Exposition, with more than 114 presentations from members of its world-leading Scientific Advisory Board (SAB) members and research grantees.
Widely regarded as the premier event in malignant and non-malignant hematology, the ASH Annual Meeting, held from December 3-6, 2016 in San Diego, CA, provides a critical forum for leading hematologists /oncologists to present their findings to over 20,000 of their peers. In keeping with its mission of eradicating lymphoma and serving those touched by this disease, scientific projects and research funded by the Lymphoma Research Foundation will account for numerous groundbreaking abstracts at this year’s meeting.
“Once again, we are extremely proud that the pivotal research stemming from the Lymphoma Research Foundation and its innovative research portfolio will be featured throughout this year’s ASH Annual Meeting,” said Dr. Leo I. Gordon, Chair of the LRF Scientific Advisory Board. “In keeping with LRF’s commitment to funding the best science with the highest likelihood of real, scalable impact, the topics presented by LRF’s grantees and SAB members are truly on the cutting edge of the most promising research presented during this year’s meeting.”
As the preeminent scientists in their field, 32 unique abstracts will be presented this year by current members of LRF’s Scientific Advisory Board, which is comprised of 45 world-renowned lymphoma experts and guides LRF research activities.
“The 2016 American Society of Hematology Annual Meeting features the groundbreaking work of numerous Lymphoma Research Foundation Scientific Advisory Board members and grantees, highlighting the Foundation’s focus on funding and working with the most accomplished scientists in the field,” said LRF Chief Executive Officer Meghan Gutierrez. “The ASH Annual Meeting also provides the unique opportunity for the scientists, clinicians and patient advocates who comprise the Foundation’s diverse research portfolio to come together to discuss the unique opportunities and challenges in lymphoma and CLL research, and strategize a path forward.”
Throughout this year’s ASH Annual Meeting, members of the Lymphoma Research Foundation Executive Team will be available for comment on ongoing ASH presentations and findings. For requests for real-time comment, please contact Peggy Ann Torney, Chief Strategy, Communications and Engagement Officer, at ptorney(at)lymphoma(dot)org or (646) 300-5506.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded nearly $60 million in lymphoma-specific research. For additional information on LRF’s research, education and services, visit lymphoma.org.